Caxton Associates (New York)’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-41,622
Closed -$391K 645
2022
Q4
$391K Sell
41,622
-159,411
-79% -$712K 0.03% 289
2022
Q3
$547K Sell
201,033
-92,615
-32% -$303K 0.07% 220
2022
Q2
$849K Buy
293,648
+196,977
+204% +$487K 0.08% 154
2022
Q1
$290K Buy
96,671
+78,165
+422% +$280K 0.02% 368
2021
Q4
$85K Hold
18,506
0.01% 530
2021
Q3
$116K Sell
18,506
-13,401
-42% -$82.8K 0.01% 422
2021
Q2
$191K Sell
31,907
-6,843
-18% -$40.6K 0.02% 424
2021
Q1
$245K Buy
38,750
+18,849
+95% +$133K 0.02% 329
2020
Q4
$112K Buy
+19,901
New +$121K 0.01% 130

Other funds holding VKTX